|
Register for OpenClinica Intensive End-User Training
Introducing OpenClinica Intensive End-User Training Pre-Scheduled Courses Now Available
Due to increasing demand, Akaza Research will be offering its most popular training course, OpenClinica Intensive End-User, on a series of pre-determined dates. To ensure the highest quality instruction, no class will have more than 5 students. The course will be delivered at Akaza's training facility in Cambridge, Massachusetts.
You can download and complete the sign-up form for training here: http://www.akazaresearch.com/OpenClinica/training.html.
Course Description:
The OpenClinica Intensive End-User course will make you an expert in using all aspects of OpenClinica designed for end-users. Students will learn how to:
- Set-up different types of studies in an optimal way within the OpenClinica software
- Use OpenClinica in a regulatory compliant manner
- Create simple-to-complex electronic Case Reports Forms (CRFs)
- Create an manage a library of case report forms
- Develop CRF edit checks / validation expressions - Set-up automatically calculated values on CRFs
- Conduct bulk import of study data
- Manage research sites and study subjects
- Manage multiple, diverse types of studies through a single instance of the software
- Create useful data sets for analysis
- Use OpenClinica for effective study monitoring and query management
- Apply best practices for creating and managing user access
- Utilize free support resources available to the OpenClinica community
This course is ideal for someone who wants to become an OpenClinica super user or will be responsible for training/teaching/supporting their colleagues. Classes are highly interactive and incorporate exercises and tailored instruction. Price per student: $3,698 USD.
2008 Remaining Course Dates:
-
July 30th – August 1st
- September 2nd – September 4th
- October 15th – October 17th
- November 17th – November 19th
- December 10th – December 12th
For questions, please send an email to enterprise@openclinica.org.
Back to News & Events index
|